Stock Market News

Dyne Therapeutics stock falls after updated plan for accelerated approval in DM1

Jun 17, 2025 - 13:02
 0
Dyne Therapeutics stock falls after updated plan for accelerated approval in DM1
Read More

Tags:

Previous Article

KFC parent Yum Brands' finance chief Chris Turner to take over as CEO

Next Article

Piper Sandler starts at SAP at Buy, highlights 'multiple tailwinds beyond 2030'

Related Posts

TSX up slightly ahead of NVIDIA earnings

May 28, 2025  0

Netherlands stocks lower at close of trade; AEX down 0.14%

Netherlands stocks lower at close of trade; AEX down 0.14%

May 30, 2025  0

Norway stocks higher at close of trade; Oslo OBX up 0.41%

May 13, 2025  0